• Company
• Xtandi closes coinsurance gap with Erleada
• by Eo, Yun-Ho Oct 17, 2023 05:27am

• Policy
• Yuhan’s Leclaza passes DREC review for 1st-line NSCLC
• by Lee, Tak-Sun Oct 16, 2023 05:24am

• Company
• Kwangdong and Moderna strengthen partnership
• by Nho, Byung Chul Oct 16, 2023 05:24am

• Company
• Lioresal Intrathecal can be prescribed in general hospitals
• by Eo, Yun-Ho Oct 16, 2023 05:24am

• Company
• Record number of reimbursed drugs listed in 1 yr
• by Chon, Seung-Hyun Oct 16, 2023 05:24am

• Company
• Will Paxlovid open a market for elderly people’s benefits?
• by Eo, Yun-Ho Oct 16, 2023 05:24am

• Policy
• Regkirona approval is for the Moon care to build up records
• by Lee, Jeong-Hwan Oct 13, 2023 05:30am

• Policy
• NA Rep Kang ‘Increase gov't support to treat breast cancer'
• by Lee, Jeong-Hwan Oct 13, 2023 05:29am

• Company
• Bayer Korea appoints JinA Lee as new Managing Director
• by Eo, Yun-Ho Oct 13, 2023 05:29am

• Policy
• The fate of the drugs identified in the inspeciton inspectio
• by Lee, Tak-Sun Oct 13, 2023 05:29am